FDA Inspection 1217174 — Strive Pharmacy Texas LLC dba Strive Pharmacy
The FDA completed an inspection of Strive Pharmacy Texas LLC dba Strive Pharmacy on September 8, 2023 in Boerne, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 8, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Boerne, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 22741 | FDCA 501(a)(2)(A) | Personnel exposure during aseptic manipulations |
| 22751 | FDCA 501(a)(2)(A) | Facility design, influx of lesser quality air |
| 22760 | FDCA 501(a)(2)(A) | Failure to clean and disinfect/sterilize equipment, ISO 5 area |